BridgeMD
New treatment option for Peripheral Artery Disease
Official title Home-based Exercise Therapy in Patients With Moderate to Severe Peripheral Artery Disease
ClinicalTrials.gov ID: NCT07655206
What this study is testing
- What it's testing
- Peripheral arterial disease (PAD) is a chronic atherosclerotic condition associated with impaired mobility, reduced quality of life, cardiovascular events, and risk of lower limb amputation. Although supervised exercise therapy (SET) is recommended for symptomatic PAD, access and adherence remain limited, particularly among patients with moderate-to-severe disease or chronic limb-threatening ischemia (CLTI).
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years or older
- Moderate-to-severe peripheral arterial disease defined by at least one of the following: ABI \< 0.6 Ankle systolic pressure \< 70 mmHg Toe systolic...
- With or without lower limb wound
- Declined referral to an in-person supervised exercise therapy program
- Able to provide informed consent
You likely can't join if
- Lower limb revascularization within the previous 30 days
- Planned revascularization during the first 12 weeks of the study
- Unable to use a portable pedal exerciser
- Unable to perform a 6-minute walk test
- Medically unstable according to the treating clinical or rehabilitation team
- Participation in a cardiovascular rehabilitation program within the previous year
The study team makes the final eligibility decision.
Where it's taking place
- Lévis, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lévis, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.